Failure of Noninvasive Ventilation in Acute Respiratory Failure is Associated with Higher Mortality in Patients with Solid Tumors: A Retrospective Cohort Study
- 20 February 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 29 (9), 1-11
- https://doi.org/10.1007/s00520-021-06078-z
Abstract
Background Noninvasive Ventilation (NIV) is a well-established treatment for Acute Respiratory Failure (ARF) in hematological cancer. However, the NIV impact on mortality in patients with solid tumors is unclear. Objective To define the factors associated with NIV failure and mortality and to describe the mortality risk of patients with solid tumors requiring NIV for ARF treatment in the intensive care unit (ICU). Methods A retrospective cohort study of patients with solid tumors admitted into an ICU between Jan 2016 and Dec 2017, for cancer treatment, with ARF diagnosis that had used the NIV as first-line treatment. Our primary outcome was ICU and in-hospital mortality. The secondary outcome was NIV failure. A Cox proportional hazards regression was used to identify variables associated with mortality and NIV failure. Kaplan-Meier analyses were performed to demonstrate cumulative survival. Results A total of 226 patients with solid tumors were included. The ICU and hospital mortality rates were 57.5% and 69.5%, respectively. NIV failed in 52.2% of the patients. The use of vasopressors (HR 2.48 [95% CI: 1.43-4.30] p = 0.001), baseline lactate (HR 1.20 [95% CI: 1.07-1.35] p = 0.003), baseline PaO2/FiO2 ratio (HR1.33 [1.11-1.55] p = 0.002), and NIV success (HR0.17 [95% CI: 0.10-0.27] p = 0.005) was independently associated with hospital mortality. The use of vasopressors (HR 2.58 [95% CI: 1.41-4.73] p = 0.02), NIV duration (HR 0.93 [95% CI: 0.89-0.97] p = 0.003), and baseline lactate (HR 1.13 [95% CI: 1.06-1.20] p = 0.001) was associated with NIV failure. Conclusions NIV failure was independently associated with an increase in both ICU and hospital mortality rates. In patients with NIV therapy indication, the duration of this intervention was associated with NIV failure.This publication has 47 references indexed in Scilit:
- Outcome and predictors of mortality in patients requiring invasive mechanical ventilation due to acute respiratory failure while undergoing ambulatory chemotherapy for solid cancersSupportive Care in Cancer, 2013
- Ventilatory support in critically ill hematology patients with respiratory failureCritical Care, 2012
- Noninvasive versus invasive ventilation for acute respiratory failure in patients with hematologic malignancies: A 5-year multicenter observational survey*Critical Care Medicine, 2011
- Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosisIntensive Care Medicine, 2011
- Prognosis of patients with haematological malignancies admitted to the intensive care unit: Sequential Organ Failure Assessment (SOFA) trend is a powerful predictor of mortalityEuropean Journal of Internal Medicine, 2011
- Mechanical Ventilation in Cancer Patients: Clinical Characteristics and OutcomesCritical Care Clinics, 2010
- Acute respiratory distress syndrome during neutropenia recoveryCritical Care, 2010
- Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock*Critical Care Medicine, 2009
- The Hospital-Survival and Prognostic Factors of Patients With Solid Tumors Admitted to an ICUAmerican Journal of Hospice and Palliative Medicine®, 2008
- Time of non-invasive ventilationIntensive Care Medicine, 2006